09/30/2026
For point-of-care cell therapies to succeed, manufacturing needs to be fully closed, automated, and ready to scale from process development into production.
๐ฃWeโre excited to share a new preprint showing how Akadeumโs BACSโข microbubble technology performs inside a fully closed, automated CAR-T manufacturing workflow. ๐ซง
Downstream, CAR-T cells from the selection step matched industry-standard manual methods across key quality metrics, including expansion, transduction, potency, and phenotype, while showing higher metabolic fitness than the conventional control.
Read the preprint to see what gentle, scalable cell selection can unlock for cell therapy manufacturing. ๐ซง